Search

Michael D. Pak

Examiner (ID: 450, Phone: (571)272-0879 , Office: P/1646 )

Most Active Art Unit
1646
Art Unit(s)
1674, 1812, 0, 1646, 1621
Total Applications
1542
Issued Applications
712
Pending Applications
275
Abandoned Applications
568

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14456277 [patent_doc_number] => 10324095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-18 [patent_title] => Methods for diagnosing osteoarthritis [patent_app_type] => utility [patent_app_number] => 15/158689 [patent_app_country] => US [patent_app_date] => 2016-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 40 [patent_no_of_words] => 18792 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15158689 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/158689
Methods for diagnosing osteoarthritis May 18, 2016 Issued
Array ( [id] => 14485175 [patent_doc_number] => 10329355 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-25 [patent_title] => Compositions and methods for targeting stromal cells for the treatment of cancer [patent_app_type] => utility [patent_app_number] => 15/158727 [patent_app_country] => US [patent_app_date] => 2016-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 36000 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15158727 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/158727
Compositions and methods for targeting stromal cells for the treatment of cancer May 18, 2016 Issued
Array ( [id] => 11491382 [patent_doc_number] => 20170065568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-09 [patent_title] => 'METHODS AND COMPOUNDS FOR CALCIUM ION CHANNEL REGULATION' [patent_app_type] => utility [patent_app_number] => 15/154140 [patent_app_country] => US [patent_app_date] => 2016-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7067 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15154140 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/154140
METHODS AND COMPOUNDS FOR CALCIUM ION CHANNEL REGULATION May 12, 2016 Abandoned
Array ( [id] => 11107632 [patent_doc_number] => 20160304603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-20 [patent_title] => 'METHODS FOR MODULATING MANNOSE CONTENT OF RECOMBINANT PROTEINS' [patent_app_type] => utility [patent_app_number] => 15/150627 [patent_app_country] => US [patent_app_date] => 2016-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16595 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15150627 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/150627
Methods for modulating mannose content of recombinant proteins May 9, 2016 Issued
Array ( [id] => 11123427 [patent_doc_number] => 20160320401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'METHOD AND APPARATUS FOR SIGNAL TRANSDUCTION PATHWAY PROFILING' [patent_app_type] => utility [patent_app_number] => 15/149843 [patent_app_country] => US [patent_app_date] => 2016-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 7213 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15149843 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/149843
METHOD AND APPARATUS FOR SIGNAL TRANSDUCTION PATHWAY PROFILING May 8, 2016 Abandoned
Array ( [id] => 11123440 [patent_doc_number] => 20160320414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'Assay for Detection of Transient Intracellular CA2+' [patent_app_type] => utility [patent_app_number] => 15/147326 [patent_app_country] => US [patent_app_date] => 2016-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 7144 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15147326 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/147326
Assay for Detection of Transient Intracellular CA2+ May 4, 2016 Abandoned
Array ( [id] => 18154098 [patent_doc_number] => 11567073 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-31 [patent_title] => Receptor tyrosine kinase biomarkers [patent_app_type] => utility [patent_app_number] => 15/569871 [patent_app_country] => US [patent_app_date] => 2016-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 4 [patent_no_of_words] => 12776 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569871 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/569871
Receptor tyrosine kinase biomarkers Apr 27, 2016 Issued
Array ( [id] => 13590063 [patent_doc_number] => 20180346580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-06 [patent_title] => Antibodies to Canine Interleukin-4 Receptor Alpha [patent_app_type] => utility [patent_app_number] => 15/562308 [patent_app_country] => US [patent_app_date] => 2016-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31991 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15562308 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/562308
Antibodies to canine interleukin-4 receptor alpha Mar 31, 2016 Issued
Array ( [id] => 13593365 [patent_doc_number] => 20180348231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-06 [patent_title] => LIGAND INDUCIBLE POLYPEPTIDE COUPLER SYSTEM [patent_app_type] => utility [patent_app_number] => 15/562290 [patent_app_country] => US [patent_app_date] => 2016-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30372 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15562290 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/562290
LIGAND INDUCIBLE POLYPEPTIDE COUPLER SYSTEM Mar 28, 2016 Abandoned
Array ( [id] => 13548781 [patent_doc_number] => 20180325938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-15 [patent_title] => METHOD OF EVALUATING OR SELECTING ANDROGEN RECEPTOR ACTIVITY REGULATOR SELECTIVE TO SEBACEOUS GLANDS OR HAIR FOLLICLES [patent_app_type] => utility [patent_app_number] => 15/531636 [patent_app_country] => US [patent_app_date] => 2016-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11290 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15531636 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/531636
METHOD OF EVALUATING OR SELECTING ANDROGEN RECEPTOR ACTIVITY REGULATOR SELECTIVE TO SEBACEOUS GLANDS OR HAIR FOLLICLES Mar 24, 2016 Abandoned
15/068412 RANDOM CONJUGATE MOLECULE AND METHODS OF MAKING AND USING THE SAME Mar 10, 2016 Abandoned
Array ( [id] => 17526859 [patent_doc_number] => 11299531 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-12 [patent_title] => Fusion protein comprising a ligand binding domain of VEGF and PDGF [patent_app_type] => utility [patent_app_number] => 15/542692 [patent_app_country] => US [patent_app_date] => 2016-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 14848 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542692 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/542692
Fusion protein comprising a ligand binding domain of VEGF and PDGF Mar 9, 2016 Issued
Array ( [id] => 12707011 [patent_doc_number] => 20180127503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-10 [patent_title] => Anti-ROR2 Antibodies [patent_app_type] => utility [patent_app_number] => 15/555036 [patent_app_country] => US [patent_app_date] => 2016-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28401 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15555036 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/555036
Anti-ROR2 antibodies Mar 9, 2016 Issued
Array ( [id] => 12425013 [patent_doc_number] => 09974842 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-22 [patent_title] => Inotropic antibodies and therapeutic uses thereof [patent_app_type] => utility [patent_app_number] => 15/062329 [patent_app_country] => US [patent_app_date] => 2016-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 14436 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15062329 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/062329
Inotropic antibodies and therapeutic uses thereof Mar 6, 2016 Issued
Array ( [id] => 13389079 [patent_doc_number] => 20180246082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => ASSAY TO DIAGNOSE AND TREAT DISORDERS OF THE ALTERNATIVE PATHWAY OF COMPLEMENT ACTIVATION [patent_app_type] => utility [patent_app_number] => 15/553826 [patent_app_country] => US [patent_app_date] => 2016-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14747 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15553826 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/553826
Assay to diagnose and treat disorders of the alternative pathway of complement activation Feb 28, 2016 Issued
Array ( [id] => 10981690 [patent_doc_number] => 20160178635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-23 [patent_title] => 'Human cellular models with biosensors' [patent_app_type] => utility [patent_app_number] => 15/055202 [patent_app_country] => US [patent_app_date] => 2016-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9821 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15055202 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/055202
Human cellular models with biosensors Feb 25, 2016 Issued
Array ( [id] => 12158834 [patent_doc_number] => 20180030100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-01 [patent_title] => 'NON-NATURAL SEMAPHORINS 3 AND THEIR MEDICAL USE' [patent_app_type] => utility [patent_app_number] => 15/552511 [patent_app_country] => US [patent_app_date] => 2016-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 57490 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15552511 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/552511
Non-natural Semaphorins 3 and their medical use Feb 22, 2016 Issued
Array ( [id] => 13814437 [patent_doc_number] => 10183979 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-22 [patent_title] => Fusion polypeptides comprising mucin-domain polypeptide linkers [patent_app_type] => utility [patent_app_number] => 15/044310 [patent_app_country] => US [patent_app_date] => 2016-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17766 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15044310 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/044310
Fusion polypeptides comprising mucin-domain polypeptide linkers Feb 15, 2016 Issued
Array ( [id] => 10791572 [patent_doc_number] => 20160137728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'ANTIBODY SPECIFICALLY BINDING TO INSULIN-LIKE GROWTH FACTOR-1' [patent_app_type] => utility [patent_app_number] => 15/003988 [patent_app_country] => US [patent_app_date] => 2016-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14705 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15003988 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/003988
Antibody specifically binding to insulin-like growth factor-1 Jan 21, 2016 Issued
Array ( [id] => 12185461 [patent_doc_number] => 20180044397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-15 [patent_title] => 'MINIMALLY-INVASIVE AND ACTIVITY-DEPENDENT CONTROL OF EXCITABLE CELLS' [patent_app_type] => utility [patent_app_number] => 15/545428 [patent_app_country] => US [patent_app_date] => 2016-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17410 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545428 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/545428
Minimally-invasive and activity-dependent control of excitable cells Jan 21, 2016 Issued
Menu